Heba K Alshaeri

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Venues

International journal of molecular sciences

Cancer management and research

Risk management and healthcare policy

Foods (Basel, Switzerland)

Fakeeh College for Medical Sciences

Massachusetts College of Pharmacy and Health Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fakeeh College for Medical Sciences

Saudi Arabia

Assistant Professor

Education History

Massachusetts College of Pharmacy and Health Sciences

United States

PHD

Publications

Wamidh H Talib, Ilia Abed, Daniah Raad, Raghad K Alomari, Ayah Jamal, Rand Jabbar, Eman Omar Amin Alhasan, Heba K Alshaeri, Moudi M Alasmari, Douglas Law
Targeting Cancer Hallmarks Using Selected Food Bioactive Compounds: Potentials for Preventive and Therapeutic Strategies. Foods (Basel, Switzerland) 13 (17) (2024)
Wamidh H Talib, Media Mohammed Baban, Mais Fuad Bulbul, Esraa Al-Zaidaneen, Aya Allan, Eiman Wasef Al-Rousan, Rahaf Hamed Yousef Ahmad, Heba K Alshaeri, Moudi M Alasmari, Douglas Law
Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action. International journal of molecular sciences 25 (17) (2024)
Reda R Mabrouk, Abdallah E Abdallah, Hazem A Mahdy, Samar A El-Kalyoubi, Omar Jamal Kamal, Tamer M Abdelghany, Mohamed F Zayed, Heba K Alshaeri, Moudi M Alasmari, Mohamed Ayman El-Zahabi
Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide Analogs. International journal of molecular sciences 24 (15) (2023)
Mohamed Ayman El-Zahabi, Faida H Bamanie, Salah Ghareeb, Heba K Alshaeri, Moudi M Alasmari, Mohamed Moustafa, Zohair Al-Marzooki, Mohamed F Zayed
Design, Synthesis, Molecular Modeling and Anti-Hyperglycemic Evaluation of Quinazoline-Sulfonylurea Hybrids as Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) and Sulfonylurea Receptor (SUR) Agonists. International journal of molecular sciences 23 (17) (2022)
Zuhair S Natto, Heba K Alshaeri
Characteristics of First Cases of Coronavirus Disease 2019 and the Effort to Prevent the Early Spread of COVID-19 in Saudi Arabia. Risk management and healthcare policy 14 (2021)
Heba K Alshaeri, Moudi M Alasmari, Zuhair S Natto, Alejandro Pino-Figueroa
Effects of Annona muricata Extract on Triple-Negative Breast Cancer Cells Mediated Through EGFR Signaling. Cancer management and research 12 (2020)

Heba K Alshaeri.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Heba K Alshaeri